Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2023

Feb 23, 2023

32853_dirs_2023-02-22_8021ec92-6d43-4306-ae2c-ca70f169d81f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2023-02-20

Reporting Person: Madaus Martin D (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-02-20 Common Stock A 29665 Acquired 76161 Direct